camptothecin has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Fan, JT; Li, J; Li, Y; Peng, YM; Su, J; Tan, NH; Yan, H; Zeng, GZ; Zhou, YB | 1 |
| Ilaš, J; Kikelj, D; Skok, Ž; Zidar, N | 1 |
| Bukowski, RM; Ganapathi, MK; Ganapathi, R; Grabowski, DR; Tabata, M; Tabata, R | 1 |
| Ganapathi, R; Tabata, M | 1 |
| Ahn, JS; Bae, EY; He, L; Jeong, SJ; Kim, A; Kim, BY; Kim, CH; Kim, KE; Kim, SO; Kwon, OS; Lee, MS; Moon, A; Shim, JH; Yoon, DY | 1 |
| Furukawa, T; Ishikawa, T; Morishima, Y; Nakagawa, H; Osawa, Y; Tamura, A; Wakabayashi, K | 1 |
| Fukuda, M; Koike, A; Ohta, T; Takeshita, T; Wu, W | 1 |
| Brodie, KM; Henderson, BR | 1 |
| Abe, M; Harada, M; Itou, M; Kawaguchi, T; Koga, H; Kuromatsu, R; Okuda, K; Sakata, M; Sata, M; Sumie, S; Taniguchi, E; Ueno, T; Yamagishi, S | 1 |
| Sakasai, R; Teraoka, H; Tibbetts, RS | 1 |
| Jaeger, C; Kratz, F; Merfort, I; Naumann, K; Schmich, K | 1 |
| Ikeda, M; Ishida, K; Kume, K; Nishizuka, SS; Shimura, T; Takemoto, K; Young, L | 1 |
| Chen, Q; Hu, J; Liu, J; Luo, X; Meng, Z; Ni, Z; Sun, Y; Tang, L; Wang, X; Xiang, F; Zhang, M; Zhang, Z; Zhu, L | 1 |
1 review(s) available for camptothecin and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA Topoisomerases, Type II; Drug Design; HSP90 Heat-Shock Proteins; Humans; Neoplasms; Topoisomerase II Inhibitors; Tubulin Modulators | 2020 |
13 other study(ies) available for camptothecin and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Rubiyunnanins C-H, cytotoxic cyclic hexapeptides from Rubia yunnanensis inhibiting nitric oxide production and NF-κB activation.
Topics: Animals; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Interferon-gamma; Lipopolysaccharides; Mice; NF-kappa B; Nitric Oxide; Oligopeptides; Peptides, Cyclic; Plant Roots; Protein Structure, Tertiary; Rubia; Tumor Necrosis Factor-alpha | 2010 |
Roles of NF-kappaB and 26 S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human nonsmall cell lung carcinoma.
Topics: Apoptosis; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; DNA; DNA Damage; DNA-Binding Proteins; Enzyme Inhibitors; Etoposide; Humans; I-kappa B Proteins; Irinotecan; Leupeptins; Lung Neoplasms; NF-kappa B; NF-KappaB Inhibitor alpha; Paclitaxel; Peptide Hydrolases; Proteasome Endopeptidase Complex; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2001 |
NF-kappa B activation in topoisomerase I inhibitor-induced apoptotic cell death in human non-small cell lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma, Non-Small-Cell Lung; DNA-Binding Proteins; Enzyme Inhibitors; Humans; I-kappa B Proteins; Irinotecan; Leupeptins; Lung Neoplasms; NF-kappa B; NF-KappaB Inhibitor alpha; Topoisomerase I Inhibitors; Transfection; Tumor Cells, Cultured | 2000 |
Caspase-3 activation as a key factor for HBx-transformed cell death.
Topics: Camptothecin; Caspase 3; Cell Death; Cell Line, Transformed; Cell Proliferation; Cell Survival; Endoplasmic Reticulum; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Leupeptins; NF-kappa B; Oligopeptides; Proto-Oncogene Proteins c-akt; Signal Transduction; Trans-Activators; Transcriptional Activation; Viral Regulatory and Accessory Proteins | 2008 |
Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Camptothecin; Cell Line; Cell Survival; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Immunoblotting; Irinotecan; Leupeptins; Lysosomes; Macrolides; Microscopy, Fluorescence; Neoplasm Proteins; Polymorphism, Single Nucleotide; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; RNA, Messenger; Time Factors; Ubiquitin | 2009 |
Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Nucleus; Cell Survival; Comet Assay; DNA Damage; DNA Repair; Epirubicin; Female; HeLa Cells; Humans; Immunohistochemistry; Irinotecan; Leupeptins; Oligopeptides; Proteasome Inhibitors; Ubiquitin | 2009 |
Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.
Topics: Active Transport, Cell Nucleus; Apoptosis; BRCA1 Protein; Camptothecin; Cell Line, Tumor; Cell Nucleolus; DNA Damage; DNA Repair; Down-Regulation; Etoposide; Humans; Leupeptins; Phosphorylation; Radiation, Ionizing; RNA, Small Interfering; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ultraviolet Rays | 2010 |
Pigment epithelium-derived factor inhibits lysosomal degradation of Bcl-xL and apoptosis in HepG2 cells.
Topics: Apoptosis; bcl-X Protein; Camptothecin; Carcinoma, Hepatocellular; Cell Cycle; Cyclophilins; Densitometry; Eye Proteins; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hep G2 Cells; Humans; Leupeptins; Liver; Liver Neoplasms; Lysosomes; Macrolides; Nerve Growth Factors; Protein Processing, Post-Translational; Recombinant Proteins; RNA, Messenger; Serpins | 2010 |
Proteasome inhibition suppresses DNA-dependent protein kinase activation caused by camptothecin.
Topics: Camptothecin; Cell Line, Tumor; Cyclin-Dependent Kinases; DNA Replication; DNA-Activated Protein Kinase; Enzyme Activation; Humans; Leupeptins; Phosphorylation; Protease Inhibitors; Proteasome Inhibitors; Replication Protein A | 2010 |
Noxa/Mcl-1 balance influences the effect of the proteasome inhibitor MG-132 in combination with anticancer agents in pancreatic cancer cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Caspase 3; Caspase 7; Cell Line, Tumor; Doxorubicin; Humans; Leupeptins; Myeloid Cell Leukemia Sequence 1 Protein; NF-kappa B; Paclitaxel; Pancreatic Neoplasms; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2 | 2012 |
Systematic Protein Level Regulation via Degradation Machinery Induced by Genotoxic Drugs.
Topics: Apoptosis; Camptothecin; Cisplatin; DNA Damage; Fluorouracil; HCT116 Cells; Humans; Irinotecan; Leupeptins; Mutagens; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteolysis; Proteome | 2016 |
Decreasing Arl4c expression by inhibition of AKT signal in human lung adenocarcinoma cells.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; ADP-Ribosylation Factors; Blotting, Western; Camptothecin; Cell Line, Tumor; Chromones; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Leupeptins; Lung Neoplasms; Morpholines; Proto-Oncogene Proteins c-akt; Signal Transduction; Smoking | 2020 |